Form 4 for CGEN COMPUGEN LTD

Accepted 2026-03-30 00:00:00 ET · period of report 2026-03-26 · accession 0001178913-26-001896 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-03-30	2026-03-26	CGEN	Levine Zurit	SVP, Business Development	M - OptEx	$0.83	+11.9K	41.2K	+40%	+$9,856
D	2026-03-30	2026-03-26	CGEN	Levine Zurit	SVP, Business Development	S - Sale+OE	$2.04	-11.9K	29.4K	-29%	-$24.2K
D	2026-03-30	2026-03-26	CGEN	Levine Zurit	SVP, Business Development	M - OptEx	$0.00	-11.9K	16.1K	-42%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2026-03-26	M	A	11,875	$0.83	41,250	D	—	—
2	Common	Ordinary Shares	2026-03-26	S	D	11,875	$2.04	29,375	D	—	—	(F2) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3	Derivative	Share Option (right to buy)	2026-03-26	M	D	11,875	$0.00	16,125	D	$0.83 · — to 2032-11-09	11,875 Ordinary Shares	(F3) This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.